Iressa Re-Challenge in Advanced NSCLC EGFR M+ Patients Who Responded to Gefitinib USed as 1st Line or Previous Treatment

Research Site, Alessandria

Research Site, Bologna

Research Site, Brescia

Research Site, Cona

Research Site, Florence

Research Site, Genova

Research Site, Lecce

Research Site, Macerata

Research Site, Meldola

Research Site, Milan

Research Site, Monza

Research Site, Napoli

Research Site, Novara

Research Site, Parma

Research Site, Perugia

Research Site, Pordenone

Research Site, Ravenna

Research Site, Rimini

Research Site, Roma

Research Site, Rozzano

Research Site, Torino

Research Site, Treviso

Research Site, Udine

Research Site, Verona